2006
DOI: 10.1259/bjr/17000205
|View full text |Cite
|
Sign up to set email alerts
|

Oesophageal dysmotility in systemic sclerosis: comparison of HRCT and scintigraphy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
32
0
4

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(38 citation statements)
references
References 22 publications
2
32
0
4
Order By: Relevance
“…It is well known that the esophagus is dilated in systemic sclerosis (Bhalla et al 1993;Pitrez et al 2006;Vonk et al 2008;Patiwetwitoon et al 2012), but its precise measurements and association with lung disease had not been done before. The finding of retained food and liquid also indicates esophageal dysfunction.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…It is well known that the esophagus is dilated in systemic sclerosis (Bhalla et al 1993;Pitrez et al 2006;Vonk et al 2008;Patiwetwitoon et al 2012), but its precise measurements and association with lung disease had not been done before. The finding of retained food and liquid also indicates esophageal dysfunction.…”
Section: Discussionmentioning
confidence: 99%
“…While several studies reported the prevalence of esophageal dilation on chest CT scans for systemic sclerosis patients, these studies used empirical cutoff values to define esophageal dilation without regard to normal standards (Bhalla et al 1993;Pitrez et al 2006;Vonk et al 2008;Patiwetwitoon et al 2012).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Routine diagnostics should include identifying specific symptoms in the patient' s history, abdominal ultrasound, upper and lower GI endocopy, an H2 breath test and even fecal calprotectin [59]. Esophageal dilatation, as seen with non-invasive HRCT, can function as a good predictor for esophagus dismotility and is superior to scintigraphy [60]. According to EULAR therapeutical recommendations, protonpump inhibitors (PPI) should be given for the prevention of gastic complications (GERD, ulcers, GAVE).…”
Section: Interstitial Lung Diseasementioning
confidence: 99%
“…[2][3][4][5][6][7][8][9] As an indicator of dysmotility in both early and advanced disease, a study has demonstrated that esophageal scintigraphy has a higher sensitivity than that of manometry and barium swallows [3], although new manometric techniques have been developed currently. However, the relationship between nuclear esophageal transit studies and reflux esophagitis has not been defined yet.…”
Section: Introductionmentioning
confidence: 99%